Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities
Net loss	$ (92,813,653)	$ (45,685,172)
Adjustments to reconcile net loss to cash flows used in operating activities
Depreciation expense	12,199,148	11,085,230
Amortization of note discounts	5,160,242	10,570,974
Impairment expense	1,748,448
Interest paid in kind	2,091,990	4,066,691
(Gain) loss on extinguishment of debt	(390,400)	4,282,220
Change in fair value of warrant liability	48,075,943	(26,733,116)
Stock-based compensation expense	5,582,634	4,523,773
Changes in operating assets and liabilities:
Accounts receivable	(1,626,759)	989,280
Prepaid expenses and other assets	(1,429,753)	(4,627,992)
Accounts payable and accrued expenses	1,113,976	29,264,412
Due to affiliates	95,399	(9,644,241)
Other liabilities	(569,844)	3,542,670
Net cash used in operating activities	(20,762,629)	(18,365,271)
Cash Flows From Investing Activities
Additions to project development costs and property and equipment	(70,734,055)	(48,614,331)
Proceeds from business combination		31,034,781
Net cash used in investing activities	(70,734,055)	(17,579,550)
Cash Flows From Financing Activities
Proceeds from notes payable	37,004,153	106,976,651
Repayments of notes payable	(39,941,576)	(62,593,562)
Payment of financing costs	(1,569,779)	(3,227,898)
Payment of Series B dividends	(193,333)
Proceeds from sale of common stock under ATM	3,099,602
Proceeds from sale of Series B preferred stock and warrants	15,200,000
Proceeds from equity raises, net of offering costs	31,746,996	26,228,499
Proceeds from exercise of warrants	23,485,200
Net cash provided by financing activities	68,831,263	67,383,690
Net (decrease) increase in cash and restricted cash	(22,665,421)	31,438,869
Cash and restricted cash, beginning of period	40,053,461	8,614,592
Cash and restricted cash, end of period	17,388,040	40,053,461
Cash	10,282,983	7,145,661
Restricted Cash	7,105,057	32,907,800
Total cash and restricted cash	17,388,040	40,053,461
Supplemental disclosure of cash flow information
Cash paid during the year for interest	3,068,627	5,962,918
Cash paid for income taxes
Non-cash investing and financing activities
Project development cost acquired through accounts payable and accrued expenses, net	5,929,913	(1,297,215)
Settlement of warrant liability	53,518,943
Non-cash contribution from PFHOF in shared services agreement		3,699,000
Accrued dividends	504,242
ATM proceeds receivable	374,377
Conversion of the preferred equity loan to common equity		58,439,625
Shares of common stock issued for accounts payable		23,426,161
Shares of common stock issued in exchange of debt		54,518,376
Conversion of GPAQ Sponsor Loan into convertible PIPE debt		500,000
Deferred financing costs in accounts payable and accrued expenses, net		610,810
Contingent beneficial conversion feature on PIPE Notes		14,166,339
Initial value of warrants accounted for as liabilities		45,845,116
Reclassify amounts from capitalized development costs to property and equipment	$ 34,938,554	$ 27,373,715